News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2023-10-19 8:5:51 am Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday InvestorPlace
2023-10-18 4:0:0 am Tiziana Life Sciences Announces Allowance By FDA For At-Home Dosing Of Intranasal Foralumab For Multiple Sclerosis Treatment GlobeNewswire
2023-10-16 4:0:0 am Tiziana Life Sciences Announces Positive Six-Month Clinical Results in Multiple Sclerosis Patients Treated with Intranasal Foralumab GlobeNewswire
2023-10-13 4:0:0 am Tiziana Announces Positive Qualitative Six-Month PET Scan Results With Intranasal Foralumab Treating Multiple Sclerosis Patients Diagnosed With Non-Active Secondary Progressive MS (na-SPMS) GlobeNewswire
2023-10-11 4:0:0 am Tiziana Announces Presentation of Six-Month Safety and Biomarker Data for Intranasal Foralumab in Patients with Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS) at the ECTRIMS Annual Congress GlobeNewswire
2023-09-26 4:0:0 am Tiziana Life Sciences Initiates Multi-Center Phase 2a Clinical Trial of Intranasal Foralumab for Non-Active Secondary Progressive Multiple Sclerosis GlobeNewswire
2023-09-12 5:19:49 am Tiziana Life Sciences' Alzheimer's treatment validated in new study News Direct
2023-09-08 4:0:0 am Tiziana Life Sciences to Participate in the H.C. Wainwright 25th Annual Global Investment Conference GlobeNewswire
2023-09-06 4:0:0 am Study Validating MoA of Intranasal Foralumab in Alzheimer’s Disease Published in the Prestigious Journal PNAS, Following FDA IND Clearance GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information